Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2016 Oct;14(4):293-294.
doi: 10.5217/ir.2016.14.4.293. Epub 2016 Oct 17.

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?

Shu Chen Wei  1
Affiliations
Editorial

Could fecal calprotectin enter mainstream use for diagnosing and monitoring inflammatory bowel disease?

Shu Chen Wei. Intest Res. 2016 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

None.

Comment on

  • Intest Res. 14:305.

References

    1. Hsu K, Champaiboon C, Guenther BD, et al. Anti-infective protective properties of S100 calgranulins. Antiinflamm Antiallergy Agents Med Chem. 2009;8:290–305. - PMC - PubMed
    1. Tibble J, Teahon K, Thjodleifsson B, et al. A simple method for assessing intestinal inflammation in Crohn's disease. Gut. 2000;47:506–513. - PMC - PubMed
    1. Chang MH, Chou JW, Chen SM, et al. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Mol Med Rep. 2014;10:522–526. - PubMed
    1. D'Haens G, Ferrante M, Vermeire S, et al. Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease. Inflamm Bowel Dis. 2012;18:2218–2224. - PubMed
    1. Lin WC, Wong JM, Tung CC, et al. Fecal calprotectin correlated with endoscopic remission for Asian inflammatory bowel disease patients. World J Gastroenterol. 2015;21:13566–13573. - PMC - PubMed

Publication types

LinkOut - more resources